Filter Results:
(3,393)
Show Results For
- All HBS Web
(3,393)
- People (9)
- News (719)
- Research (2,177)
- Events (36)
- Multimedia (27)
- Faculty Publications (1,282)
Show Results For
- All HBS Web
(3,393)
- People (9)
- News (719)
- Research (2,177)
- Events (36)
- Multimedia (27)
- Faculty Publications (1,282)
- 01 Sep 2012
- News
Start It Up
which manufactures solar-paneled generators that require only minimal diesel to help recharge their batteries. In Iraq, “I’d see huge generators running all the time but powering very little,” Moorehead said. “We take it from running 24 hours down to 4 or 5 hours a... View Details
- 22 Jan 2001
- Research & Ideas
Control Your Inventory in a World of Lean Retailing
manufacturer can increase profits and reduce inventory risks. To demonstrate that improvement, we ran a computer simulation that tests various inventory policies for three groups of SKUs in the same product line — one group with low... View Details
- 01 Mar 2016
- News
Off Script
(Thinkstock) Prescription drug spending increased by more than 13 percent in the United States in 2014, raising health insurance premiums and the ire of consumers and politicians. The reasons behind the rise are many, including the high cost of drug development—as much... View Details
- 22 Feb 2022
- News
Elevator Pitch: Good Vibrations
Illustration by Drue Wagner Illustration by Drue Wagner Bone Health Technologies Laura Yecies (MBA 1988), CEO Concept: OsteoBoost, a wearable vibration belt that is designed to treat osteopenia and prevent osteoporosis by reducing bone loss and encouraging bone growth.... View Details
- 23 Aug 2020
- News
In the UK, She Leads the Search for a COVID Vaccine
Kate Bingham (MBA 1991) Kate Bingham (MBA 1991) When she was asked to chair the UK’s Vaccine Taskforce back in May, Kate Bingham (MBA 1991) paused. Despite nearly three decades of experience as a life sciences investor with SV Health Investors, the enormity of leading... View Details
- 15 Sep 2003
- Research & Ideas
The Lessons of New-Market Disruption
Teradyne: Testing Opportunity In 1994, Teradyne, a leading provider of machines that test the quality of microprocessors and other integrated circuits as they come off the assembly line, saw an opportunity... View Details
- 23 Jul 2008
- Sharpening Your Skills
Sharpening Your Skills: Balanced Scorecard in Action
reduce the gap between strategy and execution? Does the BSC work in testing strategy? How Can The Balanced Scorecard Improve Corporate Governance? Working Paper: Improving Corporate Governance with the Balanced Scorecard The authors... View Details
- Web
Admissions Resources - Doctoral
letters, and suggestions on how to identify and approach your recommenders. Standardized Tests As you prepare for your PhD application, watch this video to learn more about what standardized tests are... View Details
- Mar 2012
- Article
Rethinking School
Economists have found that the higher a country's academic test scores, the faster its GDP grows. That puts the United States' perennially mediocre test scores in a particularly ominous light. Progress is... View Details
- January 2023
- Case
Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery
By: Regina Herzlinger and Brian Walker
What should a successful executive (HBS Baker Scholar) assess as her next move as the CEO of a firm with a promising and yet uncertain new drug? Amy Burroughs’ mandate to successfully commercialize Cleave Therapeutics’ drug for a cancer with no current successful... View Details
Keywords: Product Development; Leadership; Health Testing and Trials; Research and Development; Risk and Uncertainty; Financial Condition; Partners and Partnerships; Pharmaceutical Industry
Herzlinger, Regina, and Brian Walker. "Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery." Harvard Business School Case 323-045, January 2023.
- February 2009
- Case
Avid Radiopharmaceuticals: The Venture Debt Question
By: Matthew Rhodes-Kropf and Ann Leamon
The CEO of a promising biotech company must decide how to respond to the macro-economic slump of late 2008. He had planned to pursue an aggressive schedule, moving the firm's Alzheimer's and Parkinson's disease imaging compounds through clinical trials and into the... View Details
Keywords: Financial Crisis; Entrepreneurship; Borrowing and Debt; Venture Capital; Financial Management; Investment; Health Testing and Trials; Expansion; Biotechnology Industry; Pharmaceutical Industry
Rhodes-Kropf, Matthew, and Ann Leamon. "Avid Radiopharmaceuticals: The Venture Debt Question." Harvard Business School Case 809-086, February 2009.
- 01 Dec 2011
- News
Research With Impact: Changing Global Health Practices
Professor Ashraf (center) with members of the study implementation team at Chipata Clinic, Lusaka, Zambia, including fi eld managers, surveyors, community health workers, and a study nurse. (click for larger view) Read a summary of Ashraf's recent presentation at HBS... View Details
- 15 Jun 2020
- Research & Ideas
A Mass Crisis Can Overwhelm Health Care. Liberia Found a Solution.
test people, then process the tests and take them to a waiting area.” When Ebola began ravaging the country in 2014, Liberia’s government came knocking on Last Mile Health’s door. The organization helped the... View Details
- April 2014 (Revised July 2015)
- Case
Sanofi Pasteur: The Dengue Vaccine Dilemma
By: V. Kasturi Rangan, David E. Bloom, Vincent Dessain and Emilie Billaud
In 2012, Sanofi Pasteur was racing to develop a vaccine against dengue, a mosquito-borne disease, and was evaluating this product in a Phase IIb trial conducted with school children in Thailand. But while the candidate vaccine met the high safety expectations and a... View Details
Keywords: Health Testing and Trials; Product Launch; Market Entry and Exit; Emerging Markets; Pharmaceutical Industry; France
Rangan, V. Kasturi, David E. Bloom, Vincent Dessain, and Emilie Billaud. "Sanofi Pasteur: The Dengue Vaccine Dilemma." Harvard Business School Case 514-074, April 2014. (Revised July 2015.)
- June 2004 (Revised November 2004)
- Case
Acorda Therapeutics: Rebuilding the Spinal Cord
Acorda is an early-stage life science start-up with a promising product that is close to reaching the market (Phase III clinical trials). The company is grappling with how to expand its portfolio of molecules to make the business more sustainable. It faces classic... View Details
Keywords: Decision Making; Science-Based Business; Health Testing and Trials; Business Startups; Product Development; Biotechnology Industry
Enriquez-Cabot, Juan, Jonathan West, Marina Kolesnik, and Fiona Murray. "Acorda Therapeutics: Rebuilding the Spinal Cord." Harvard Business School Case 604-014, June 2004. (Revised November 2004.)
- 2009
- Working Paper
Where Is the Pharmacy to the World? International Regulatory Variation and Pharmaceutical Industry Location
By: Arthur Daemmrich
A consumer-oriented model for drug development and use has attracted attention in recent years as an alternative to the much-maligned approach of mass-marketing blockbuster drugs. In a parallel development, patients and disease-based organizations have assumed greater... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Disorders; Health Testing and Trials; Power and Influence; Competitive Strategy; Pharmaceutical Industry; European Union; Germany; United States
Daemmrich, Arthur. "Where Is the Pharmacy to the World? International Regulatory Variation and Pharmaceutical Industry Location." Harvard Business School Working Paper, No. 09-118, April 2009.
- 18 Mar 2001
- Research & Ideas
The Essentials for Enlightened Experimentation
incentives to encourage rapid experimentation. Consider using small development groups that contain key people (designers, test engineers, manufacturing engineers) with all the knowledge required to iterate rapidly. Determine what... View Details
Keywords: by Stefan Thomke
- Web
Launch Lab/Capstone 1 - Course Catalog
rigorous system engineering methods to plan, design, develop, build, and test a complex technology-based product/service, integrating knowledge across multiple engineering disciplines. Business Knowledge: The use of business model... View Details
- Web
Comparison of Output with Hours of Sleep – The Human Relations Movement – Baker Library, Historical Collections
HBS Home HBS Index Contact Us Back to Exhibit Page Comparison of Output with Hours of Sleep First Relay Assembly Test Group, ca. 1930 Western Electric Company Hawthorne Studies Collection © 2007 President and Fellows of Harvard College;... View Details
- 01 Jun 2024
- News
The Bookshelf: Try As One Might
the grasp of anyone who made it through high school chemistry. But effective experimentation is often poorly understood in practice, Liedtka says, and businesses that test their ideas without a solid understanding of experimental design... View Details